Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Johnson & Johnson Options Spot-On: On April 18th, 83,692 Contracts Were Traded, With 416.29K Open Interest
On April 18th ET, $Johnson & Johnson(JNJ.US)$ had active options trading, with a total trading volume of 83,692 options for the day, of which put options accounted for 68.72% of the total transactions
Pfizer Options Spot-On: On April 18th, 131.6K Contracts Were Traded, With 3.26 Million Open Interest
On April 18th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 131.6K options for the day, of which put options accounted for 40.43% of the total transactions, and call
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 780.4K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 18, $Vericel(VCEL.US)$ Officer Colangelo Dominick intends to sell 17,500 shares of its common stock on Apr 18, with a total market value of approximately $780.4K. Colange
Gilead Sciences Publishes 2023 ESG Impact Report
NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and
What the Options Market Tells Us About Gilead Sciences
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:GILD), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga un